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Abstract
Background: Investigations on adverse biological effects of nanoparticles (NPs) in the lung by in vitro studies are usually
performed under submerged conditions where NPs are suspended in cell culture media. However, the behaviour of nanoparticles
such as agglomeration and sedimentation in such complex suspensions is difficult to control and hence the deposited cellular dose
often remains unknown. Moreover, the cellular responses to NPs under submerged culture conditions might differ from those
observed at physiological settings at the air–liquid interface.
Results: In order to avoid problems because of an altered behaviour of the nanoparticles in cell culture medium and to mimic a
more realistic situation relevant for inhalation, human A549 lung epithelial cells were exposed to aerosols at the air–liquid inter-
phase (ALI) by using the ALI deposition apparatus (ALIDA). The application of an electrostatic field allowed for particle deposi-
tion efficiencies that were higher by a factor of more than 20 compared to the unmodified VITROCELL deposition system. We
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studied two different amorphous silica nanoparticles (particles produced by flame synthesis and particles produced in suspension by
the Stöber method). Aerosols with well-defined particle sizes and concentrations were generated by using a commercial electro-
spray generator or an atomizer. Only the electrospray method allowed for the generation of an aerosol containing monodisperse
NPs. However, the deposited mass and surface dose of the particles was too low to induce cellular responses. Therefore, we gener-
ated the aerosol with an atomizer which supplied agglomerates and thus allowed a particle deposition with a three orders of magni-
tude higher mass and of surface doses on lung cells that induced significant biological effects. The deposited dose was estimated
and independently validated by measurements using either transmission electron microscopy or, in case of labelled NPs, by fluores-
cence analyses. Surprisingly, cells exposed at the ALI were less sensitive to silica NPs as evidenced by reduced cytotoxicity and
inflammatory responses.
Conclusion: Amorphous silica NPs induced qualitatively similar cellular responses under submerged conditions and at the ALI.
However, submerged exposure to NPs triggers stronger effects at much lower cellular doses. Hence, more studies are warranted to
decipher whether cells at the ALI are in general less vulnerable to NPs or specific NPs show different activities dependent on the
exposure method.
Introduction
Amorphous SiO2 nanoparticles (NPs) are regarded as only little
pathogenic. However, it has been shown that the inhalation of
silica NPs induces transient inflammation in rats [1,2]. Mean-
while there are numerous reports which also demonstrate
adverse effects of amorphous silica NPs in vitro, e.g., in
macrophages [3-5], in lung epithelial cells [5-8] and in
co-cultures of both cell types [9]. However, in vitro exposure of
lung cells under submerged conditions does not reflect the
physiological situation in the lung where cells are directly
exposed to an aerosol. Especially our findings of a strong
inhibitory effect of serum proteins on NP toxicity show how the
standard cell culture model generates artefacts and might lead to
wrong conclusions [5]. Additionally, particle collection and
resuspension in medium may change their physico-chemical
properties and the particle dose delivered to the cells under
submerged conditions is often unclear due to differences in
agglomeration and sedimentation of suspended NPs. In vitro
experiments at the air–liquid interface (ALI) are therefore of
utmost relevance.
Although exposure of cells at the air–liquid interface (ALI)
represents a more realistic exposure scenario compared to
submerged exposure only few research papers are found in the
literature, in particular for silica NPs [10]. This is due to the
need for more sophisticated laboratory equipment, technical
know-how and, additionally, for the generation of a nanomate-
rial aerosol in a reproducible manner. A recent review prepared
by toxicologists and aerosol scientists states the urgent need for
further developments of in vitro cell exposure studies including
those at the air–liquid interface [11]. Advantages of ALI expo-
sures are (a) the modification of particles by filter collection and
resuspension in medium are avoided, (b) the nanoparticle dose
interacting with the cells can be controlled more precisely and
(c) the exposure of lung cells at ALI resembles an in vivo
inhalation more closely. Several exposure systems for the
controlled exposure of cells to particles at the ALI have recently
been developed. Most ALI systems described in the literature
rely on the deposition of nanoparticles by diffusion mecha-
nisms [12-17].
Due to the small size of the nanoparticles the mass and surface
doses that can be applied on the cell surface through ALI expo-
sures are very low compared to the typical “lowest observed
adverse effect levels” (LOAEL) derived from submerged exper-
iments [18]. One approach to increase the applied dose is the
use of nanoparticle agglomerates. However, especially in the
size regime between 100 nm and 500 nm deposition efficien-
cies of ALI exposure chambers based on diffusion or gravita-
tional settling are usually very low [19]. One approach to
increase the deposition rates is the use of an electrostatic field
[20-23]. This enables deposition efficiencies of up to 100% for
charged particles [11]. de Bruijne et al. [21] used a corona
charger for efficient charging of aerosol particles and did not
observe adverse effects on A549 cells by the trace gases formed
in the corona. However, for particle sizes below 50 nm, the
probability to be charged becomes low [24] and hence the depo-
sition efficiency of such systems decreases.
In this study we used a well-characterised commercially avail-
able exposure chamber system (VITROCELL® SYSTEMS)
that we equipped with electrodes to enhance deposition by
applying an electrostatic field (referred to in the following as
ALI deposition apparatus, ALIDA) [18]. Aerosols with well-
defined particle sizes and concentrations were generated by
using commercial electrospray generators or atomizers. The
deposited dose was determined by using transmission electron
microscopy (TEM) and in case of labelled NPs by fluorescence
analyses. Industrial SiO2 NPs (Aerosil
®200, Evonik) produced
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Figure 1: Temporal evolution of SiO2 particle size distributions generated for cell exposure. (A) From an aqueous solution of SiO2-50 nm monomers
(Stöber synthesis, Postnova) high number concentrations of airborne SiO2-50 nm monomers with a narrow size distribution were generated by elec-
trospray. The atomizer, however, generated from the same nanoparticle suspension large agglomerates (B) allowing for the deposition of high mass
doses. Large agglomerates with a broad size distribution were also generated by atomizing Aerosil200 (C). Initial size distributions are given on the
left hand side of each time chart.
by flame synthesis and SiO2 NPs produced by the Stöber
method (Postnova Analytics, Landsberg) were used to test the
biological responses in A549 cells with and without an electro-
static field at the ALI and under submerged conditions.
Results and Discussion
Aerosols
The aerosols were generated by two different methods: an
atomizer and electrospray. By using the electrospray method it
was possible to generate an aerosol containing monomers and
small agglomerates of SiO2-50 nm NPs with a high number
concentration and a narrow size distribution (Figure 1A). This
method was however not applicable for the dispersion of
Aerosil200 suspensions which contain aggregates that were too
large for a stable operation of the electrospray in the cone jet
mode. Therefore, an atomizer was used that delivered a rela-
tively large and broad droplet size distribution [25] and, with
Aerosil200, an aerosol with constant but broad size distribution
(Figure 1C). Furthermore, dispersion of SiO2-50 nm NPs with
the atomizer allowed for the generation of large agglomerates
(Figure 1B) which resulted in high mass and surface doses.
Particle deposition
The aerosol was directed into the ALI deposition apparatus
(ALIDA) as described in section Experimental and the particles
were deposited on Transwell membranes covered with test cells
without or with applying an electrostatic field (Figure 2).
Figure 2: Schematic view of the Vitrocell® exposure chamber modi-
fied with an electrode for electrostatic particle deposition.
In order to increase the deposition efficiency the exposure
chambers were modified with an electrode similar to the setup
presented by Savi et al. [20]. In contrast to Savi et al. who used
an alternating electrical field, during the exposure experiments a
constant voltage of 1 kV was used in this study. Furthermore,
no insulation between electrode and cell medium was installed,
so that the cells themselves can be considered as an equipoten-
tial surface and electrode, respectively. This makes a close dis-
tance between electrode and cells unnecessary and allows for
the use of larger medium volumes. As counter electrode a fine
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Table 1: Characteristics of the particles, the aerosol generation and deposition with electrostatic field.
Aerosil200 atomizer SiO2-50 nm atomizer SiO2-50 nm
electrospray
primary particle size (TEM) (7–100) nma (54 ± 3) nmb (54 ± 3) nmb
specific surface area 200 m2·g−1 c 60 m2·g−1 d 60 m2·g−1 d
aerosol generation
concentration of the suspension used for aerosol
generation
1 mg·mL−1 3.25 mg·mL−1 7 mg·mL−1
mean (agglomerate) mobility diameter in air
(SMPS)
(279 ± 10) nm (230 ± 10) nm (53 ± 1)nm
agglomerate fractione 100% 92% 7%
particle deposition
exposure duration 5 h 7 h 5 h
mass dose (TEM) (52 ± 26) µg·cm−2 (117 ± 46) µg·cm−2 (0.14 ± 0.05) µg·cm−2
surface dose (TEM) (104 ± 52) cm2·cm−2 (70 ± 28) cm2·cm−2 (0.08 ± 0.03) cm2·cm−2
number dose (TEM) (2.0 ± 0.8) × 108 cm−2 (1.4 ± 0.3) × 109 cm−2 (6 ± 2) × 108 cm−2
deposition efficiency — — (11 ± 3)%
experiments per endpoint 3 2 2
aThe manufacturer calculated a primary particle size of 12 nm from the BET surface. bThe manufacturer states a size of 70 nm analysed by DLS.
cGiven by the manufacturer. dValue was estimated from the primary particle size. eObtained by analysis of size distributions and TEM pictures [18].
conducting mesh was placed 2 mm above the cell surface at the
end of the aerosol inlet.
The electrical field was almost homogeneous with an axial
strength of 500 V·mm−1. A computer simulation revealed that
only at the outer border of the Transwell membranes (more than
10 mm distance from the center of the membrane) a significant
inhomogeneity of the field is expected due to increasing radial
components in the electrical field strength (Figure 3). These
radial components however, cause a force in radial direction
and hence provide a more homogeneous particle deposition on
the cell surface than a purely homogeneous field profile.
For determination of the cellular dose cell-free Transwell
membranes carrying one or more grids for transmission elec-
tron microscopy (TEM) were exposed to the aerosol under the
same conditions as the cells and analysed for particle loading.
Deposition of SiO2-50 nm NPs
The SiO2-50 nm particles were produced by the Stöber method
and provided by the manufacturer as an aqueous suspension
containing monomeric particles. For preparing an aerosol the
suspension was diluted with water by factors of 3.6 and 7.7 for
electrospray and the atomizer, respectively. The electrospray
generated aerosol particles with a mean mobility size of
(53 ± 1) nm (σ = 1.2) and a typical number concentration of
(1.3 ± 0.2) × 106 cm−3. The uncertainties stated are, if not
defined otherwise, standard deviations of all experiments done
and the parameter σ characterises the standard deviation of a
log-normal size distribution. After the exposure of empty
Figure 3: Electrostatic potential within the exposure chambers.
Assuming a flat equipotential surface the electrostatic potential was
1 kV at the cell level. The dashed lines indicate the borders of the
Transwell membrane. The field profile was simulated with SimIon (SIS,
v8). Isolating parts of the Transwell insert and chamber were
neglected.
Transwell membranes loaded with TEM grids to SiO2-50 nm
monomers generated by electrospray and deposited with the
electrostatic field a total number dose of (6 ± 2) × 108 cm−2 was
determined by analysis of the TEM pictures (Table 1). Further-
more, a mean projection equivalent diameter of the particles of
(54 ± 3) nm (σ = 1.1) was measured on the TEM grids in very
good agreement with the diameter of the airborne particles.
Since the particles were not homogeneously distributed over the
entire Transwell membrane (Figure 4) the total number dose
corresponds to a mean particle number dose. Compared to the
total applied particle number this dose is equivalent to a deposi-
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Figure 4: Deposition efficiency of SiO2 monomers depending on particle size (left plot) with electrostatic field (symbols) and without electrostatic field
(SiO2 particle characteristics and drawn line as in Comouth et al. [18] and deposition efficiency of SiO2-50 nm monomers in dependence of the pos-
ition on the Transwell surface (plot on the right)). SiO2-50 nm monomers were dispersed by electrospray and deposited on a Transwell surface with
electrostatic field. The deposited mass was calculated from particle loadings on TEM grids at three different radial positions on the Transwell surface
from the center to the edge. The dashed line indicates the averaged deposition efficiency. The results indicate a moderate but significant linear
decrease of the particle loading between the center and the edge of the Transwell membranes.
tion efficiency of (11 ± 3)% which is 22-fold higher compared
to 0.5% achieved with this exposure chamber without electro-
static field for particles of this size [18]. However, due to the
small monomer size the corresponding mass and surface dose
after 5 h of exposure only amounts to (0.14 ± 0.05) µg·cm−2 and
(0.08 ± 0.03) cm2·cm−2, respectively (see Table 1).
In contrast to the electrospray the atomizer delivered an
agglomerate fraction of about 92% (data not shown) with a
mean mobility diameter of (230 ± 10) nm (σ = 1.8) (Figure 1)
and typical number concentrations of (7 ± 1) × 105 cm−3.
Compared to the particles in the aerosol a slightly larger mean
projection equivalent diameter of (270 ± 30) nm (σ = 1.9) was
observed to be deposited (Figure 5B) with a total number dose
of (1.4 ± 0.3) × 109 cm−2. Reasons for these different sizes are
the size-dependent deposition efficiency and different equiva-
lent diameters that were used for size classification with SMPS
and TEM, respectively. The latter one, however, may be negli-
gible due to the almost compact spherical structure of the
agglomerates (Figure 5D). Small agglomerates showed struc-
tures similar to the clusters described by Cho et al. [26] and
Manoharan et al. [27]. More than 95% of the mass however
were provided by agglomerates larger than 200 nm mobility
equivalent diameter. Agglomerates of this size contain more
than 40 monomers so that errors due to different effective densi-
ties of small agglomerates and monomers are also assumed to
be negligible. The mass dose resulting from analysis of the
TEM micrographs as a function of the applied mass is shown in
Figure 5A. Within the uncertainties TEM and fluorescence data
are in very good agreement and can be described by a linear
function of the applied particle mass. For the cell exposures a
mean mass dose of (117 ± 46) µg·cm−2 follows from this func-
tion. This is within the dose range of classical nanotoxicology
studies under submerged conditions and beyond the lowest
observed adverse effect level (LOAEL) defined for, e.g.,
Aerosil200 in lung epithelial cells [5].
Deposition of Aerosil200
Aerosil200 are industrial SiO2 NPs produced by flame syn-
thesis and provided as a powder. The manufacturer states a
mean primary particle size of 12 nm. However, our analyses by
TEM revealed monomeric particle sizes between 7 and 100 nm
almost exclusively forming larger agglomerates. For preparing
an aerosol the powder was suspended in water and ultrasoni-
cated. The hydrodynamic diameter determined by DLS in water
was (215 ± 25) nm as also reported previously [5]. The mean
sizes of the aerosolized and deposited Aerosil200 agglomerates
were (279 ± 10) nm (σ = 1.8) mean mobility equivalent and
(491 ± 40) nm (σ = 2.25) mean projected area equivalent diam-
eter, respectively (Figure 6B), and hence even larger compared
to the SiO2-50 nm particles (Table 1). Please note that the larger
difference between the two given equivalent particle diameters
is caused by the fluffy structure of the Aerosil200 agglomerates
since the measured mobility equivalent diameter corresponds to
the diameter of a hypothetical compact sphere with the same
dynamic mobility as the agglomerates and the projected area
equivalent diameter to that of a circle with the same area as the
projected area of the agglomerates under the microscope [28].
Due to smaller deposited number concentrations of (2.0 ± 0.8) ×
108 cm−2, the corresponding mean mass dose determined from
TEM micrographs and measured effective densities was only
(52 ± 26) µg·cm−2. The analysis of TEM pictures assuming
compact agglomerates results in the upper limit of this mass
dose (78 µg·cm−2). However, the true deposited dose is presum-
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Figure 5: Characteristics of deposited SiO2-50 nm agglomerates. Aerosols of fluorescently labeled SiO2-50 nm agglomerates were generated by an
atomizer and deposited on Transwell membranes with an applied electrostatic field. The deposited mass was either detected by measuring fluores-
cence intensity or using TEM analysis of particle loaded grids. (A) shows the deposited mass as a function of the applied mass by the two detection
methods. The size distribution of the corresponding particles on a TEM grid is shown in (B). (C) shows the particle loading on TEM grids after seven
hours of exposure corresponding to a mass dose of (117 ± 46) µg·cm−2 and (D) representative clusters at higher magnification indicating the spher-
ical agglomerate shape. Please note that the applied mass in (A) is given in arbitrary units (third power of the mobility equivalent diameter) and neither
the effective density nor the total particle size range was considered. Hence the slope of the linear fit is not equal to the mean mass deposition effi-
ciency.
Figure 6: Deposited mass (derived from the number of particles) of Aerosil200 agglomerates as a function of the applied mass (A), size distribution of
the corresponding particles (B), as well as the particle loading on a TEM grid after five hours of exposure corresponding to a mass dose of
(52 ± 26) µg·cm−2 (C), and a representative cluster indicating the agglomerate shape (D). Please note that the applied mass in (A) is given in arbi-
trary units (third power of the mobility equivalent diameter) and neither the effective density nor the total particle size range was considered. Hence
the slope of the linear fit is not equal to the mean mass deposition efficiency.
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Figure 7: Effects of ALI and submerged exposure to (Aerosil200) and SiO2-50 nm agglomerate NPs (B) on the integrity of the membrane of A549
cells determined by LDH release. A549 cells were exposed to filtered air or to aerosols containing Aerosil200 NPs (A) or SiO2-50 nm NPs (B) under
ALI conditions with application of an electrode (+). Controls were exposed to filtered air with or without electrode (−). The mass doses after ALI expo-
sure were 52 µg·cm−2 for Aerosil200 NPs after 5 h and 117 µg·cm−2 for SiO2-50 nm NPs after 7 h. Subsequently, cells were post-incubated in
medium without FCS and supernatants were processed 24 h after the onset of exposure. For comparison, cells were treated for 24 h with an esti-
mated maximal dose of 15.6 µg·cm−2 (50 µg·mL−1) applied as suspension in medium without FCS or with medium alone. Results are means ± s.e.m.
of 4 to 6 samples originating from three (A) and two independent experiments (B).
ably lower as the effective densities of larger agglomerates are
decreased. Aerosol particle mass (APM) measurements deliv-
ered effective densities of (0.81 ± 0.02), (0.53 ± 0.02) and
(0.39 ± 0.01) g·cm−3 for particle mobility equivalent sizes of
80 nm, 250 nm, and 800 nm, respectively, which is 34–68%
less than estimated when considering the rather compact
SiO2-50 nm agglomerates. This is in agreement with TEM
micrographs that show a more complex cluster structure
compared to SiO2-50 nm agglomerates that cannot be described
by a packing of hard spheres (Figure 6D). We assume this struc-
ture is caused by strongly bonded agglomerates and aggregates
present in Aerosil200 after its synthesis in gas phase as reported
by Seipenbusch et al. [29]. Such strong particle interactions
prevent the monomers from restructuring within the atomized
droplets. Hence Aerosil200 agglomerates are rather composed
of irregular shaped aggregates [30] than of spherical monomers
behaving like hard spheres. For this reason the actual effective
density decreases with increasing agglomerate size (Figure S1,
Supporting Information File 1). Therefore, the minimal dose of
26 µg·cm−2 was calculated considering only the lowest effec-
tive density for the largest agglomerates, which, however, is
obviously underestimating the final deposited mass. Hence, the
actual dose will be within the calculated extremes and is given
as (52 ± 26) µg·cm−2.
Biological effects
For the determination of biological effects the Transwell inserts
covered with a confluent layer of A549 cells were exposed to
filtered and unfiltered aerosol. Exposure to the unfiltered
aerosol of Aerosil200 NP and SiO2-50 nm NP agglomerates led
to deposited doses of 52 µg·cm−2 and of 117 µg·cm−2, respect-
ively (see Table 1), which roughly leads to similar surface doses
of about 104 cm2·cm−2 for Aerosil200 and 70 cm2·cm−2 for
SiO2-50 nm NPs.
For the comparison with submerged exposure to silica NPs, the
cells in Transwell inserts were treated with 50 µg·mL−1 NP
suspensions in medium without FCS. The cellular dose was
estimated according to the computational model of Hinderliter
et al. [31]. The particle dose delivered to the cells is determined
by diffusion and sedimentation processes, which are dependent
on the particle sizes [31]. Aerosil200 NPs are detected as
agglomerates in cell culture medium with an average hydrody-
namic diameter of (220 ± 6) nm in the freshly prepared suspen-
sion and remain stable up to 24 h (Table S1, Supporting Infor-
mation File 1). In contrast, SiO2-50 nm NPs are mainly present
as (72 ± 19) nm NPs directly after dispersion but are also
detected to a minor extent as larger agglomerates of about 2 μm
after 24 h (Table S1, Supporting Information File 1). The final
calculated deposited mass after 24 h is nearly identical for both
Aerosil200 and SiO2-50 nm NP suspensions and amounts to
7.0 µg·cm−2 (Figure S2, Supporting Information File 1).
Figure 7 shows that the electrical field and the exposure to
filtered air had no effect on the release of lactate dehydroge-
nase (LDH) into the medium. Enhanced levels of LDH indicate
membrane damage, which leads to cell death. LDH values of
the ALI-exposed control samples were similar to those detected
under submerged conditions. In contrast, exposure to silica NPs
induced strong LDH release under submerged exposure condi-
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Figure 8: Release of IL-8 from A549 cells after submerged and ALI exposure to Aerosil200 and SiO2-50 nm NP agglomerates. A549 cells were
exposed to filtered air or to an aerosol containing Aerosil200 NPs (A) and SiO2-50 nm NPs (B) under ALI or submerged conditions as described in
Figure 7 above. IL-8 concentrations in the medium are represented as means ± s.e.m. of 4 to 6 samples originating from three (A) and two inde-
pendent experiments (B).
tions. The LDH release after submerged exposure to
15.6 µg·cm−2 (50 µg·mL−1) Aerosil200 indicates 100% cell
lysis as it was comparable to the LDH release from Triton
X-100-treated cells, which were used as positive controls in
some experiments (data not shown). However, cells exposed to
NPs in the ALI system were less sensitive compared to
submerged exposure. Under both conditions, SiO2-50 nm NPs
were less effective in reducing the membrane integrity than
Aerosil200 NPs.
The medium was also analysed for the release of the pro-
inflammatory cytokines IL-8 and IL-6. Figure 8 shows, that the
electrical field and the exposure to clean air had no effect on
IL-8 release. The results at the ALI were qualitatively compa-
rable with those obtained under submerged conditions. Expo-
sure to silica NPs induced a strong release of IL-8 under
submerged exposure conditions. Cells exposed to NPs at the
ALI, however, released much lower IL-8 levels. Again under
both conditions, as also seen for the release of LDH above,
SiO2-50 nm NPs were less effective than Aerosil200 NPs. IL-6
release was not detected after ALI exposure to silica NPs and
was only moderately enhanced after submerged exposure (data
not shown). For comparison, a positive control for IL-6 and
IL-8 release has been previously analysed under submerged
conditions in medium without FCS [5]. Lipopolysaccharide
(LPS, 10 µg·mL−1) induced the release of about 1000 pg·mL−1
of IL-8 and 10 pg·mL−1 of IL-6 after 24 h, respectively.
To analyse the biological effects of NPs at earlier points in time,
cells were lysed immediately after ALI or submerged exposure.
Phosphorylation of the MAP kinase p38 and induction of the
inflammatory protein COX-2 were determined by Western blot.
Figure 9A and Figure 9C show that Aerosil200 NPs induced
similar levels of p38 phosphorylation and COX-2 after
submerged and ALI exposure although the deposited dose under
submerged conditions was lower than at the ALI. Similar to the
findings described above for the release of LDH and IL-8,
induction of COX-2 by SiO2-50 nm NPs was also less
pronounced when compared to Aerosil200 NPs (Figure 9B,D).
However, the relative phosphorylation of p38 seems to be
enhanced at the ALI when compared to Aerosil200 or to
submerged exposure. As p38 phosphorylation was detected
after 7 h of exposure whereas LDH and IL-8 release were moni-
tored after 24 h, a more detailed kinetic analysis is needed to
substantiate a possibly different regulation of this biomarker in
response to SiO2-50 nm NPs.
Our studies on the biological effects of Aerosil200 under
submerged conditions confirm results obtained previously [5].
Here we compare them directly with the effects of Stöber-
synthesized silica NPs SiO2-50 nm and additionally compare
them to an ALI exposure method. The results after ALI expo-
sure showed that both silica NPs qualitatively induced the same
toxic and pro-inflammatory effects as after submerged expo-
sure, however, quantitatively much less pronounced. During
ALI exposure the particle dose was linearly applied over a time
period of 5 h (Aerosil200) and 7 h (SiO2-50 nm) and thereafter
remained constant (Figure S2, Supporting Information File 1).
For submerged conditions, particles continuously settle down
onto the cells in dependence of the agglomeration state and the
viscosity of the medium [31,32]. Therefore, the constant
mechanical stress imposed by particle deposition might explain
the increased sensitivity of cells under submerged culture condi-
tions. Indeed, the importance of shear forces to exacerbate
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Figure 9: Induction of COX-2 und phosphorylation of p38 in A549 cells after SiO2-NP treatment under submerged and ALI conditions. A549 cells
were exposed to filtered air or to an aerosol containing Aerosil200 NPs (A) and SiO2-50 nm NPs (B) as described in Figure 7 above. COX-2 and
phospho-p38 were detected in whole cell lysates by Western blots. PCNA (left panel), Lamin B (right panel) and total p38 were used as loading
controls, as indicated. The results shown are representative for three (A) and two independent experiments (B). (C) and (D) show the quantification of
the p-p38 and COX-2 bands normalized to the loading controls (total p38 and PCNA or Lamin B, respectively), which are compared to the ALI
controls exposed to clean air without electrode (which are set to 1).
NP-induced toxicity has been described previously [8,33].
Another explanation could also be the secretion of surfactant by
A549 cells under ALI conditions [34] which may have a protec-
tive effect due to binding of surfactant proteins to the particles
[35].
Furthermore, Aerosil200 NPs induced similar but more intense
cellular responses compared to SiO2-50 nm NPs. A possible
reason could be the higher specific surface area of the
Aerosil200 NPs with 200 m2·g−1 compared to 60 m2·g−1 of the
SiO2-50 nm NPs. The dependence of biological effects on
particle size and specific surface area is well known and has
already been shown for many types of particles including amor-
phous silica particles [36].
Conclusion
In this study two silica NPs produced by different synthesis
methods were intensively characterized with regard to their
properties in aerosols, deposition from the aerosol onto cells
and biological endpoints under ALI and submerged conditions.
We could confirm our previous finding with SiO2 NP suspen-
sions from another manufacturer (Ludox AS40) that the genera-
tion of an aerosol that contains monomeric silica particles is
possible when using an electrospray generator [18]. Further-
more, a VITROCELL® exposure module was modified and
equipped with electrodes to allow electrostatic deposition
enhancement by more than a factor of about 20. However,
although the deposited particle number for monomeric silica
particles of 53 nm diameter was comparable to those of agglom-
erated silica particles the mass and surface doses were too low
to induce significant biological effects in lung cells. Therefore,
an atomizer was used to generate aerosols with larger agglomer-
ates allowing application of mass and surface doses that were
up to three orders of magnitude higher.
Both types of silica NPs induced cytotoxicity and inflammatory
responses under conventional submerged conditions. At the
same nominal applied dose Aerosil200 NPs were more toxic
than 50 nm silica NPs produced by the Stöber method.
However, when considering the specific surface area both NPs
show similar potencies. This supports previous findings that
presumably the interaction of cells with the silica surface trig-
gers adverse effects. Surprisingly, at the ALI the apparent toxi-
city of both NPs was drastically reduced although the deposited
Beilstein J. Nanotechnol. 2014, 5, 1590–1602.
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mass was higher by a factor of three to seven. The underlying
reasons for the different sensitivity remain unknown. Future
studies need to address the relevance of changes in the dose rate
as a critical parameter for cellular toxicity. Moreover, more
detailed analysis of particle uptake (e.g., by confocal
microscopy or TEM) under ALI and submerged conditions will
be helpful to unravel the different responses. This study is one
of only a handful of similar attempts to directly compare bio-
logical effects of NPs under ALI and submerged conditions. In
a triple-culture comprised of human lung epithelial cells,
macrophages and dendritic cells were exposed to similar doses
of ZnO particles under submerged and ALI conditions. Interest-
ingly, the response (LDH release, HO-1 induction) occurred
more rapidly at the ALI but to a similar extend [37]. Similarly,
exposure of A549 cells to ZnO particles at the ALI provoked a
stronger increase in pro-inflammatory gene expression and the
concentrations of particles to induce the lowest observed effect
levels were reduced [38]. Moreover, gold nanoparticles were
deposited with the previous system but, in contrast to some
other submerged studies, did not induce adverse effects [39].
Also a mono-culture of bronchial 16HBE14o cells induced IL-8
already at much lower diesel exhaust particle concentrations
deposited at the ALI in comparison to submerged exposure
[40]. ALI and submerged exposure have also recently been
compared for their response to a chemical inducer of oxidative
stress. In line with our findings, a tetra-culture of A549, THP-1,
mast and endothelial cells reacted more sensitive under clas-
sical submerged conditions with respect to release of IL-8 and
production of ROS [10]. Therefore, more NPs with different
chemistries and sizes as well as different cell culture models
need to be assessed in order to either confirm a reduced toxicity
of NPs at the ALI in general or rather to identify a NP-specific
behaviour that depends on the exposure method. Furthermore, it
is possible that at the ALI gene expression will change
compared to submerged cultures, a topic which warrants further
investigations. Indeed, human bronchial epithelial cells are
more resistant to stress imposed by ambient air pollution parti-
cles and decrease expression of the pro-inflammatory marker
IL-8 and the anti-oxidant gene heme oxygenase 1 (HOX1)
when cultivated at the ALI prior to exposure [41]. However,
first studies in A549 cells for those selected genes do not indi-
cate major changes in expression within a few hours of cultiva-
tion at the ALI [38].
Recently, the concept of “dose rate” as a critical driver of toxi-
city was again promoted [42]. In animal experiments, instilla-
tion of high doses of titania NPs initiates inflammation whereas
deposition of the same mass by inhalation is almost without
effect. The difference between the two approaches is a drasti-
cally increased dose rate (micrograms per minute) when using
instillation versus inhalation. However, the interpretation of
such in vivo experiments is complicated, because not only the
dose rates differ, but also the distribution of the NPs within the
lung and the clearance are different. As in our in vitro studies
these two confounding factors are eliminated, the dose rate still
remains an important determinant to possibly explain the differ-
ences in toxicity when exposing cells at the ALI and under
conventional submerged conditions. However, in our study the
dose rate is considerably lower for the submerged versus ALI
deposition and therefore does not correlate with increased toxi-
city. This raises of course the question which dose rates are
most realistic and how comparable different studies are.
Presumably, the use of other ALI systems delivering the dose
almost instantly (bolus deposition), and thus avoiding the neces-
sity to incorporate sophisticated humidification systems as used
in our ALIDA, will also provide different outcomes because at
the even higher dose rate the relative response to NPs might
change. Certainly, a systematic comparison of different
air–liquid-interface methods including classical submerged
toxicological assays is needed to assess the relevance of dose
and dose rate and to finally relate results obtained from such in
vitro methods to data obtained from exposure studies with
animals or even humans.
Experimental
Materials
Aerosil®200 powder was kindly provided by Evonik (Essen,
Germany). The SiO2-50 nm NPs without or with labelling with
fluorescein isothiocyanate (FITC) supplied as a monodisperse
solution of 25 mg/mL in water were from Postnova Analytics
(Z-PS-SIL-GFP-0.07, Landsberg am Lech, Germany).
Dulbecco’s Modified Eagle Medium (DMEM), Roswell Park
Memorial Institute medium (RPMI-1640), Hank’s Balanced
Salt Solution (HBSS), Dulbecco’s Phosphate Buffered Saline
without Ca2+ and Mg2+ (DPBS-/-), penicillin, streptomycin, and
trypsin were from Life Technologies (Frankfurt am Main,
Germany). Fetal calf serum (FCS) was from PAA (Cölbe,
Germany). The cytotoxicity detection kit for determining
release of LDH was from Roche (Mannheim, Germany).
Enzyme-linked immuno assays (ELISA) for the detection of
human IL-6 and IL-8 were from BD Biosciences (OptEIA kits,
Heidelberg, Germany). 4-(2-Hydroxyethyl)piperazine-1-ethane-
sulfonic acid (HEPES) and the chemicals for sodium dodecyl-
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) were
from Carl Roth (Karlsruhe, Germany). For the Western blots
Immobilon-P PVDF membranes (Millipore, Eschborn,
Germany), primary antibodies against COX-2 (Biozol, Eching,
Germany), phospho-p38 (Thr 180/ Tyr 182, Cell Signalling,
Frankfurt am Main, Germany), PCNA (PC-10), Lamin B
(M-20) and p38 (C-20) (both from Santa Cruz), HRP-conju-
gated secondary antibodies (DAKO, Hamburg) and the
enhanced chemiluminescence (ECL) detection system
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from GE Healthcare (Freiburg, Germany) were used.
Transwell® inserts containing polyester membranes of 24 mm
diameter and with pores of 0.4 µm (Cat.No. 3450) were from
Corning Life Sciences (Amsterdam, The Netherlands). 75-mesh
formvar-coated copper grids for transmission electron
microscopy (TEM) were from Plano GmbH (Wetzlar,
Germany).
Aerosol generation and characterisation
For cell exposure to nanoparticle monomers the monodisperse
SiO2-50 nm NP suspensions were dispersed into synthetic air
(Air Liquide, 20% O2 in N2, less than 3 ppm impurities) by
using an electrospray aerosol generator (TSI 3480, Shoreview,
United States) as described by Comouth et al. [18]. To ensure
agglomerate fractions of less than 7% the suspension was
diluted to 7 mg·mL−1 with Nanopure water (type 1 ultrapure
water, Barnstead, Germany). In addition to the electrospray an
Atomizer (Topas, ATM 220, Dresden, Germany) was used for
aerosol generation. The particle number concentrations and size
distributions of the aerosol were continuously measured by
using a scanning mobility particle sizer (SMPS, TSI, Aachen,
DMA 3081 and CPC 3025).
Exposure of cells to aerosol
The cells were exposed to the aerosol with the ALIDA expo-
sure system described in detail by Comouth et al. [18]. For cell
exposure the aerosol was humidified to 80–90% relative
humidity at 37.5 °C. The humidified aerosol was then carried
with identical flows of 100 mL·min−1 (sccm) through six tubes
of equal dimensions to the inlets of six exposure chambers
(VITROCELL Systems GmbH, Waldkirch). Two stainless steel
modules were equipped with three Transwell® inserts of 24 mm
membrane diameter. To increase the deposition efficiency an
almost homogeneous electrical field with an axial strength of
500 V·mm−1 was applied.
Determination of the dose
In order to determine the deposited fraction of the applied
aerosol during ALI exposure TEM grids (Plano, SF162-6) were
placed on the Transwell membranes at three different radial
positions and exposed to the aerosol for different times. Subse-
quently, 50 micrographs of the deposited particles were taken
for each experiment by using a transmission electron micro-
scope (Zeiss 109T, Oberkochen). The deposited particles were
detected and analysed regarding their number and size with a
custom-made software.
For the calculation of mass doses spherical primary particles
with a density of 2 g·cm−3 were assumed. This value is close to
the 1.8–2.2 g·cm−3 stated by the manufacturer (Postnova
Analytics) and to literature data for amorphous silica particles
of 2.2 g·cm−3 [43]. For agglomerates remaining from droplets
containing more than one particle an effective density cannot
easily be defined. For hard spheres Manoharan et al. [27]
suggested that the particles are configured in spherical pack-
ings with structures that minimize the second moment of the
mass distribution. Hence we treated large agglomerates as
compact spherical clusters with volume fractal dimensions close
to 3. Furthermore we assumed a volume filling factor of 1.56
assuming a polytetrahedral structure. In order to justify this
simplification the deposited mass dose of the FITC-labeled
SiO2-50 nm particles was estimated additionally from their
fluorescent intensity. Therefore, the exposed Transwell inserts
were filled with 0.8 mL distilled water to suspend the deposited
particles. The fluorescence of the solution was measured at
(485 ± 10) nm excitation and (530 ± 12) nm emission wave-
lengths by using a Bio-Tec FL600 spectrometer and the soft-
ware package KC4 (MWG-Biotech AG, Ebersberg, Germany).
At the same time Transwell inserts filled with 0.8 mL of
suspensions containing FITC-labeled SiO2-50 nm NPs at
0.25 mg·mL−1, 0.5 mg·mL−1 and 1 mg·mL−1 were used for cali-
bration. Since Aerosil200 particles are not fluorescent this
procedure could not be applied to verify the corresponding
TEM results. In order to give at least a lower limit of the mass
dose the effective density of 80 to 800 nm sized agglomerates
was measured by using an Aerosol Particle Mass (APM)
analyser (Kanomax, APM 3601) [44] in combination with a
differential mobility analyser (DMA) connected upstream. The
total amount of deposited particles was estimated finally by
extrapolating the amount of deposited particles as a function of
the applied particle mass.
Cell culture
The human alveolar epithelial cell line A549 obtained from
American Type Culture Collection (ATCC, Rockville, MD)
was maintained in DMEM supplemented with 10% (v/v) FCS,
2 mM L-glutamine, 100 U·mL−1 penicillin, and 100 mg·mL−1
streptomycin at 5% CO2 at 37 °C. The cells were passaged
every three to four days. Two days before ALI exposure experi-
ments 4 × 105 cells in 1 mL of RPMI-1640 medium with
10% FCS were seeded per Transwell insert with a surface
area of 4.7 cm2. This corresponds to a cell density of
8.5 × 104 cells·cm−2. At the day of exposure cells formed a
confluent monolayer as assessed by microscopy.
Submerged treatment of cells
The Aerosil200 particles were suspended in cell culture medium
without 10% FCS at 10 mg·mL−1 and probe-sonified (Branson
Sonifier, 250, Schwäbisch Gmünd, Germany) for 50 s (50 duty
cycles, output 5) right before preparing dilutions and adding to
cells. The SiO2-50 nm particles were diluted in medium and
vortexed.
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Exposure of cells under ALI conditions
Shortly before the experiment the medium above the cells and
under the membrane was removed and both sides were washed
with HBSS. 1.5 mL RPMI1640 medium without sodium bicar-
bonate, prepared from RPMI1640 powder, containing 10 mM
HEPES, 100 U·mL−1 penicillin, 100 mg·mL−1 streptomycin and
without FCS was pipetted into the basal compartment and the
apical compartment was covered by a thin layer of 100 µL
HBSS (ca. 214 µm initial mean layer height) in order to avoid
drying out of the cells. RPMI instead of DMEM was used for
growing cells at the ALI as it allowed a better maintenance of a
stable pH which is required to keep cells viable. The cells were
transported to the ALIDA system in a pre-warmed and ther-
mally insulated box and exposed. Two inserts with cells were
exposed to clean air which was generated by passing the humid-
ified and conditioned aerosol through HEPA air filters
(HepaVent™ Y271, Whatman GmbH, Dassel). Three other
inserts were exposed to the unfiltered aerosol and one equipped
with TEM grids for dose determination. Each exposure was
done with and without applying an electrostatic field enhancing
the deposition efficiency.
Determination of biological effects
After the ALI exposure the cells were either directly lysed or
further incubated under submerged conditions in serum-free
RPMI medium without HEPES at 37 °C and 95% humidity and
analysed after 24 h. Post-incubation was performed submerged
in order to allow optimal release of cytokines into the apical
compartment. For comparison, cells grown in Transwell inserts
were simultaneously treated under submerged conditions in
serum-free RPMI medium for the same time periods. The cell
lysates were analysed for COX-2 and phosphorylated p38 by
Western blot. The media of the post-incubated cells were
analysed for release of LDH by using a test kit from Roche
according to the manufacturer’s instructions. Release of IL-6
and IL-8 was analysed by enzyme-linked immune assay
(ELISA) kits from Becton Dickinson according to the manufac-
turer’s instructions.
Western blots
Whole cells were lysed with 2× Lämmli SDS Buffer (160 mM
Tris·HCl pH 6.8, 4% SDS, 20% glycerol, 4% ß-mercapto-
ethanol). The cell lysates were boiled at 95 °C for 5 min, probe
sonified for 15 s and then stored at −20 °C. Equal amounts of
the lysates were loaded onto 10% SDS-polyacrylamide gels and
after electrophoresis, the proteins were transferred onto Immo-
bilon-P PVDF membranes. The membranes were blocked with
5% (w/v) non-fat dry milk in 1% Tween20 in Tris-buffered
saline (TBS) for 1 h. For the detection of phosphorylated p38
the membranes were blocked in 3% (w/v) BSA. The blots were
then incubated with primary antibodies and subsequently with
HRP-conjugated secondary antibodies which were finally
detected with the ECL system.
Supporting Information
Supporting Information contains 1) data obtained by
dynamic light scattering of the particles suspensions 2) data
on the deposited mass dose for Aerosil200 particles after
ALI exposure and 3) deposition kinetics of the mass doses
for Aerosil200 and SiO2-50 nm particles during ALI and
submerged exposure.
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